Academic Urology Unit

Medicine & Life Sciences

1. Systematic Reviews 100%
2. Urology 59%
3. Randomized Controlled Trials 46%
4. Prostatic Neoplasms 41%
5. Urinary Incontinence 35%
6. Meta-Analysis 33%
7. Guidelines 33%
8. Cost-Benefit Analysis 29%
9. Urinary Bladder Neoplasms 28%
10. Stress Urinary Incontinence 27%
11. Transurethral Resection of Prostate 27%
12. Lower Urinary Tract Symptoms 21%
13. Therapeutics 20%
14. Suburethral Slings 20%
15. Prostate 19%
16. Quality of Life 17%
17. Pelvic Floor 17%
18. Practice Guidelines 17%
19. Urinary Bladder 15%
20. Lithotripsy 15%
21. Confidence Intervals 14%
22. Renal Cell Carcinoma 14%
23. Costs and Cost Analysis 13%
24. Ureteroscopy 13%
25. Urinary Tract Infections 13%
26. Catheterization 12%
27. Urinary Catheters 11%
28. Odds Ratio 11%
29. Urodynamics 11%
30. MEDLINE 11%
31. Muscles 11%
32. Prostatectomy 10%
33. Economics 10%
34. Urologic Neoplasms 10%
35. Tamsulosin 10%
36. Delivery of Health Care 10%
37. Prostatic Hyperplasia 9%
38. Catheters 9%
39. Recurrence 9%
40. Lymph Node Excision 9%
41. Congresses 9%
42. Prospective Studies 9%
43. Patient Participation 8%
44. Cystectomy 8%
45. Placebos 8%
46. Network Meta-Analysis 8%
47. Antibiotic Prophylaxis 8%
48. Conservative Treatment 7%
49. Urethral Stricture 7%
50. Uncertainty 7%
51. Kidney Neoplasms 7%
52. Indwelling Catheters 7%
53. Biopsy 7%
54. Percutaneous Nephrolithotomy 7%
55. Quality-Adjusted Life Years 7%
56. Guideline Adherence 7%
57. Nephrectomy 7%
58. Equivalence Trials 6%
59. Neoplasms 6%
60. Education 6%
61. Electric Stimulation 6%
62. Patient Reported Outcome Measures 6%
63. Urinary Diversion 6%
64. Chronic Kidney Failure 6%
65. Kidney 6%
66. Consensus 6%
67. Urinary Retention 6%
68. Ureter 6%
69. Nifedipine 5%
70. Intermittent Urethral Catheterization 5%
71. Health Care Outcome Assessment 5%
72. Equipment and Supplies 5%
73. Penile Neoplasms 5%
74. Databases 5%
75. Medication Therapy Management 5%
76. Clinical Trials 5%
77. Random Allocation 5%
78. Urinary Tract 5%
79. Overactive Urinary Bladder 5%
80. Decision Making 5%
81. Data Analysis 5%
82. Nitrofurazone 5%